KRYS
KRYS
NASDAQ · Biotechnology

Krystal Biotech Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$254.95
+7.86 (+3.18%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -66.0% upside
Low Target $54.31
Average Target $86.77
High Target $114.95
Current Price $254.95
Current
$254.95
Target
$86.77
$54.31 $86.77 avg $114.95
Scenario Analysis
Bear Case
$54.31
-78.7%
Low target
Base Case
$86.77
-66.0%
Avg target
Bull Case
$114.95
+-54.9%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$298.30
-14.5% from high
52-Week Low
$122.80
+107.6% from low
50-Day SMA
$263.07
-3.1% vs SMA
200-Day SMA
$186.47
+36.7% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$86.77
-70.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%